Retinitis pigmentosa (RP) is an inherited, degenerative eye disease that causes severe vision impairment and often blindness. The progress of RP is not consistent. Some people will exhibit symptoms from infancy, others may not notice symptoms until later in life. Generally, the later the onset, the more rapid is the deterioration in sight. Also notice that people who do not have RP have 90 degree peripheral vision, while some people that have RP have less than 90 degree.
A form of retinal dystrophy, RP is caused by abnormalities of the photoreceptors (rods and cones) or the retinal pigment epithelium (RPE) of the retina leading to progressive sight loss. Affected individuals may experience defective light to dark, dark to light adaptation or nyctalopia (night blindness), as the result of the degeneration of the peripheral visual field (known as tunnel vision). Sometimes, central vision is lost first causing the person to look sidelong at objects.
Ophthalmology and Carolina Stem Cell Treatment Center
At Carolina Stem Cell Treatment Center and Cell Surgical Network, we have been studying the effects of SVF (rich in mesenchymal stem cells and growth factors) on various ophthalmologic conditions including Macular degeneration, retinitis pigmentosa, diabetic retinopathy, retinal detachments, Glaucoma, Leber’s optic neuropathy and optic neuritis. In collaboration with our opthalmology consultants we have designed protocols for visual loss conditions that emphasize safety and efficacy. The CSCTC deployment protocol performed under local anesthesia is all done as an outpatient at the time of SVF harvesting and procurement . The entire cellular surgical procedure takes approximately 3 hours.
Retinitis Pigmentosa Call to Action
We care about our Retinitis Pigmentosa patients at Carolina Stem Cell Treatment Center an affiliate of CSN. We take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out the CSCTC Confidential Candidate Application, we will answer the questions and concerns you may have about CSCTC and CSN protocols for Retinitis Pigmentosa problems.